Research and Markets


Printer Friendly

Printed from http://www.researchandmarkets.com/reports/45280


The Pharmaceutical Market: Portugal


Description: THE PHARMACEUTICAL MARKET: PORTUGAL - REVIEW

The macroenvironment remains tough for the Portuguese pharmaceutical market. Politically, the new Prime Minister aims to create a more efficient state and comply with the bail-out commitments signed by the previous socialist government. The austerity programme is expected to remain high on his agenda. Economically, the Economist Intelligence Unit (EIU) believes that economic and fiscal policy will be shaped by the bail-out agreement signed with the EU and the IMF. There are signs that public hospitals will be affected as part of the country’s effort to reduce its budget deficit. Legally, IPR regulations are harmonised with EU procedures. Demographically, Portugal has one of the smallest population in Western Europe, but the EIU projects that the number of people aged 65 years and over will increase to represent 18.8% of the total population in 2016, equal to 2.0 million people.

Pharmaceutical sales growth will be negligible in the forecast period. In US dollar terms, pharmaceutical sales in Portugal are expected to rise in 2011, due to a weaker exchange of the US dollar against the euro, and to fall between 2012 and 2016, affected by a stronger projected exchange rate. In euro terms, pharmaceutical sales are projected to increase modestly in the forecast period, due to the government’s cost-containment measures. In 2016, the Portuguese pharmaceutical market will be one of the smallest in Western Europe, ranking 12th. In per capita terms, Portugal will have the lowest pharmaceutical expenditure. The new Minister of Health is very keen to encourage further generic consumption, with a new proposal submitted in September 2011.

Improved regulation has encouraged generic sales in Portugal, but prices have been slashed in recent years. Generic sales rose by 4.5% in local terms in 2010, and recorded a market share of 19.1%. In volume terms, generic sales rose by 10.9% in 2010, and recorded a market share of 18.3%; contrary to what happens in other markets, generics sales in Portugal have a higher market share in value than in volume. The generic market is very fragmented, with many companies that have a low market share. Leading national generic producers include Farmoz (part of Tecnimede), Generis (part of Farma-APS), Medinfar, Hovione, Bluepharma and ToLife. Foreign generic producers include Mylan, ratiopharm (now part of Teva), Alter, Fresenius Kabi (via Labesfal) Stada, Actavis and Winthrop.

ENHANCED STRATEGIC INTELLIGENCE

These highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting the pharmaceutical market in context. The reports provide:

- Five-year projections for economic, demographic, health expenditure, health workforce and pharmaceutical market indicators.
- Specialised intelligence on OTCs, generics, biologics and biosimilars.
- Exclusive economic and demographic data from the Economist Intelligence Unit (EIU) for each market in the series.
- A separate statistical health file, comprising health expenditure, health infrastructure, health services and health personnel.
- The reports are updated quarterly, providing you with the latest information for a full year. In addition, the service will keep you up to date with market and industry news on a regular basis.

HEALTHCARE STATISTICS

A comprehensive tabula review, comprising demographics, epidemiology, health expenditure, hospital and primary care infrastructure & services and healthcare personnel, is additionally included.


Contents: HEALTHCARE STATISTICS

A comprehensive tabula review, comprising demographics, epidemiology, health expenditure, hospital and primary care infrastructure & services and healthcare personnel, is additionally included.

EXECUTIVE SUMMARY
Including Espicom's at a glance strategic analysis and key data projections

MACROENVIRONMENT
Political, economic, legal and demographic analysis

EPIDEMIOLOGY
Disease burden and prevalence

HEALTHCARE
Organisation, expenditure, infrastructure, services and workforce

REGULATORY AFFAIRS
Regulatory developments and marketing registration/authorisation

PRICING & REIMBURSEMENT

DISTRIBUTION CHANNELS

MARKET ANALYSIS
Projections, product development, manufacturing and trade

COMPETITION
Trade associations, trade fairs, company intelligence and competitive strategies

OTC PHARMACEUTICALS

GENERIC PHARMACEUTICALS

BIOLOGICS & BIOSIMILARS

OPPORTUNITIES & CHALLENGES
Espicom's unique strategic analysis

DIRECTORY

METHODOLOGY & SOURCES


Companies Mentioned Companies Mentioned Include: - Bial - Bluepharma - Hikma Farmacêutica Portugal - Hovione - Jaba - Medinfar - Labotorios Vitória - Pharmout - Apifarma - Apogen


Ordering: Order Online - visit http://www.researchandmarkets.com/reports/45280

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


Research and Markets Page 1 of 2
Printed 13/02/2012 08:22:47
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to
646-607-1907 (from USA) or +353 1 6849977 (from Rest of World). If you have any questions please email help@researchandmarkets.net

Order information
Please verify that the product information is correct and select the format you require.
Product Name:
The Pharmaceutical Market: Portugal
Web Address:
http://www.researchandmarkets.com/reports/45280
Office Code:
OC8IHINLSNNSS

Report formats
Please enter the quantity of the report format you require.

Format Quantity Price
Electronic (Online Access) - Enterprisewide €5,050.00
Electronic (PDF) - Enterprisewide €5,050.00
Electronic (Online Access) - Single User €775.00
Hard Copy €775.00 + EUR€ 50.00 Shipping/Handling *
Electronic (PDF) - Single User €775.00
* Shipping/Handling is only charged once per order.


Contact information
Please enter all the information below in BLOCK CAPITALS.

First Name:   Last Name:  
Email Address:
Job Title:
Organisation:
Address:
City:
Postal/Zip Code:
Country:
Phone Number:
Fax Number:


Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)
Research and Markets Page 2 of 2
Printed 13/02/2012 08:22:47

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

 Pay by Credit Card:
American Express
Diners Club
Master Card
Visa
Cardholder's Name:
Cardholder's Signature:
Expiry Date: /
Card Number:
CVV Security Code:
Issue Date: /   (Diners Club only)


 Pay by Check:
Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


 Pay by Wire Transfer:
Please transfer funds to:

Account number: 83313083
Sort code: 98-53-30
Swift code: ULSBIE2D
IBAN number: IE78ULSB98533083313083
Bank Address: Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland.
If you have a Marketing Code please enter it below:
Marketing Code:


Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)